95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.91%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.92%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-16.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10.50%
Negative net income growth while NEM stands at 22.98%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.67%
Negative EPS growth while NEM is at 22.22%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while NEM is at 22.22%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.61%
Share count expansion well above NEM's 0.22%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.64%
Diluted share change of 1.64% while NEM is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-13.76%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
156.85%
10Y revenue/share CAGR above 1.5x NEM's 30.90%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-43.56%
Negative 5Y CAGR while NEM stands at 13.03%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
90.09%
3Y revenue/share CAGR above 1.5x NEM's 11.49%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
3232.53%
Positive OCF/share growth while NEM is negative. John Neff might see a comparative advantage in operational cash viability.
785.71%
Positive 3Y OCF/share CAGR while NEM is negative. John Neff might see a big short-term edge in operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
2933.79%
5Y net income/share CAGR above 1.5x NEM's 359.52%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
658.94%
3Y net income/share CAGR above 1.5x NEM's 57.02%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
698.75%
10Y equity/share CAGR above 1.5x NEM's 137.76%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
729.85%
5Y equity/share CAGR above 1.5x NEM's 169.48%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1036.77%
3Y equity/share CAGR above 1.5x NEM's 37.50%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
3.87%
Asset growth above 1.5x NEM's 1.96%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
2.31%
BV/share growth above 1.5x NEM's 0.65%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.62%
We cut SG&A while NEM invests at 78.38%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.